Key industry demands are around expanding the PLI scheme for manufacturing in deeptech — this includes green energy, advanced materials, and semiconductors.
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of ...
Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance ...
Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from ...
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report)’s share price gapped up before the market opened on Wednesday after HC Wainwright raised their price target on the stock from $28.00 to $33.
Dr. Roger Hollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing gene replacement therapies using blood stem ...
Arkema S.A. (Colombes, France) and OOYOO Ltd., a Japanese start-up, signed a partnership agreement to develop high-performance gas-separation membrane ...
Inhale a smaller dose, though, and you will merely become mildly oxygen-deprived. If you are oxygen-deprived for long enough, the shortage will stimulate your bone marrow to ramp up the production of ...